ArticleJournal of Cancer2020

MiR-186 bidirectionally regulates cisplatin sensitivity of ovarian cancer cells via suppressing targets PIK3R3 and PTEN and upregulating APAF1 expression.

Ying Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.